Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

Not Applicable

Terminated

Conditions: Colon Cancer

Interventions: Drug: FOLFOX and bevacizumab

First Posted Date: 2009-01-22

Last Posted Date: 2015-04-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT00826800

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

and more 2 locations

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Recruiting

Conditions: Breast Cancer

Interventions: Other: Blood draw and questionnaires

First Posted Date: 2009-01-15

Last Posted Date: 2024-07-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 609

Registration Number: NCT00823654

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 5 locations

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Dasatinib and Paclitaxel

First Posted Date: 2009-01-12

Last Posted Date: 2019-08-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT00820170

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Procedure: Stem cell transplant x 1 or x 2
Drug: lenalidomide and dexamethasone

First Posted Date: 2008-12-12

Last Posted Date: 2019-03-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 67

Registration Number: NCT00807599

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

and more 4 locations

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Paclitaxel
Drug: Pemetrexed
Drug: Bevacizumab

First Posted Date: 2008-12-12

Last Posted Date: 2015-12-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 44

Registration Number: NCT00807573

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan-Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 2 locations

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium

Phase 2

Completed

Conditions: Bladder Cancer
Metastatic Transitional Cell Carcinoma

Interventions: Drug: Everolimus

First Posted Date: 2008-12-09

Last Posted Date: 2022-11-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 46

Registration Number: NCT00805129

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Penile Exam, Peyronie's Plaque and Erectile function assessment

First Posted Date: 2008-12-02

Last Posted Date: 2014-07-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 121

Registration Number: NCT00800813

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Study of Vaginal Dilator Use After Pelvic Radiotherapy

Completed

Conditions: Endometrial Cancer
Anal Cancer
Rectal Cancer
Cervical Cancer

Interventions: Device: Vaginal Dilator

First Posted Date: 2008-11-13

Last Posted Date: 2015-06-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 115

Registration Number: NCT00789893

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Phase 2

Completed

Conditions: Malignant Glioma
Brain Cancer

Interventions: Other: radiotherapy (RT) in combination with temozolomide and bevacizumab

First Posted Date: 2008-10-31

Last Posted Date: 2018-02-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT00782756

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: perifosine

First Posted Date: 2008-10-21

Last Posted Date: 2017-08-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT00776867

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy